Adaptive Biotechnologies logo

ADPT - Adaptive Biotechnologies News Story

$33.5 1.7  5.5%

Last Trade - 8:15pm

Sector
Healthcare
Size
Large Cap
Market Cap £3.04bn
Enterprise Value £2.62bn
Revenue £60.1m
Position in Universe 1363rd / 6432

BRIEF-Adaptive Biotechnologies Receives Expanded Medicare Coverage Of Clonoseq For Monitoring Mrd In Patients With Chronic Lymphocytic Leukemia

Wed 8th January, 2020 12:40pm
Jan 8 (Reuters) - Adaptive Biotechnologies Corp  ADPT.O :
    * ADAPTIVE BIOTECHNOLOGIES RECEIVES EXPANDED MEDICARE
COVERAGE OF
CLONOSEQ FOR MONITORING MRD IN PATIENTS WITH CHRONIC LYMPHOCYTIC
LEUKEMIA

Source text for Eikon:  ID:nGNX93MscH 
Further company coverage:  ADPT.O 

 ((Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.